CAMBRIDGE, Mass., May 08, 2018 (GLOBE NEWSWIRE) — Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today reported financial results and business highlights for the first quarter ended March 31, 2018. First Quarter 2018 Financial Highlights Total net revenues of $18.0 million compared to $9.4 million in the first quarter of 2017; first quarter […]